Newsfeeds - Spark Newswire

3 minute read

The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More

Today, 3:49 PM

Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news flow continued to dominate proceedings, and the week also witnessed presentations at conferences and a couple of initial public offerings.

ADPT

32 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 3:49 PM

On Thursday, 615 stocks hit new 52-week lows.

AAOI

1 minute read

Events
News

Adaptive Biotechnologies Announces New Data Demonstrating The Benefit Of Serial MRD Testing With The clonoSEQ Assay In Patients With Blood Cancers At The 63rd ASH Annual Meeting

By Benzinga Newsdesk

Today, 3:49 PM

Analysis of the MASTER trial (Abstract 481) showed clonoSEQ's ability to measure deep and durable responses and permit treatment discontinuation in multiple myeloma patients Data in more than 30

ADPT

6 minute read

Adaptive Biotechnologies, Collaborators To Present Over 30 Abstracts On Utility Of clonoSEQ In MRD Testing In Blood Cancer Patients At 63rd ASH Annual Meeting On Dec. 11-14

By Benzinga Newsdesk

Today, 3:49 PM

ADPT

3 minute read

12 Publicly Traded Companies On Fast Company’s ‘Next Big Things In Tech’ List

By Chris Katje

Today, 3:49 PM

Real-world problem solvers are highlighted in the inaugural “Next Big Things In Tech” list by Fast Company. The list included 65 honorees from big companies to start-ups. The names on the list were picked by 14 editors and writers at the magazine.

ADBE

2 minute read

FDA
News

Adaptive Biotechnologies Receives Updated Medicare Coverage For Its Minimal Residual Disease (MRD) Assay, clonoSEQ For Blood Cancer Patients

By Benzinga Newsdesk

Today, 3:49 PM

Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced that Palmetto GBA's Molecular Diagnostics Program (MolDX) has finalized a local coverage determination (LCD) whic

ADPT

1 minute read

Cathie Wood’s ARK Invest Posts Fund Purchases For Monday, Nov. 8, 2021: ZM, EXAS, ADPT, PACB, HOOD

By Benzinga Newsdesk

Today, 3:49 PM

Zoom Video Communications (ZM) Exact Sciences (EXAS) Adaptive Biotechnologies (ADPT) Pacific Biosciences of California (PACB) Robinhood Markets (HOOD)

ADPT

1 minute read

Cathie Wood’s ARK Invest Posts Fund Purchases For Wednesday, Nov. 3, 2021

By Benzinga Newsdesk

Today, 3:49 PM

Zoom Video (ZM) Exact Sciences (EXAS) Twilio (TWLO) Robinhood (HOOD) UIPath (PATH) DraftKings (DKNG) Intellia Therapeutics (NTLA) Beam Therapeutics (BEAM) Teladoc (TDOC) NIU Technologies

ADPT

1 minute read

Adaptive Biotechnologies Q3 EPS $(0.40) Beats $(0.42) Estimate, Sales $39.50M Beat $36.64M Estimate

By Benzinga Newsdesk

Today, 3:49 PM

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.42) by 4.76 percent. This is a 48.15 percent decrease over losses of $(0.27) per

ADPT

25 minute read

Earnings Scheduled For November 3, 2021

By Benzinga Insights

Today, 3:49 PM

Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.

AAWW